Evidence map›Paper›PMID 20944100›Full record

ArticleAnticancer research2010

NF-kappaB inhibitors from Brucea javanica exhibiting intracellular effects on reactive oxygen species.

Jeong-Ah Kim, Edward K Lau, Li Pan, Esperanza J Carcache De Blanco

Open access · greenAbstract read
In one paragraph

Article in Anticancer research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Quassinoids as Promising Anti-cancer Agents.Current medicinal chemistry · 2025
    Review
  2. A Concise Enantioselective Approach to Quassinoids.Journal of the American Chemical Society · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. World journal of gastroenterology · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Research of Brucea javanica against cancer.Chinese journal of integrative medicine · 2017
    Review
  13. Article
  14. Article
  15. Ambiguine I Isonitrile fromInternational journal of cancer research · 2015
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeong-Ah KimDivision of Pharmacy Practice and Administration, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Edward K Lau
Li Pan
Esperanza J Carcache De Blanco
The Ohio State University · US

Funding

Project 3:Isolation Chemistry of Filamentous Fungi and Biological EvaluationP01CA125066 · NCI · OHIO STATE UNIVERSITY · PI JAMES R FUCHS · 2007 to 2026
$27.2M
NCI NIH HHS P01 CA125066NCI NIH HHS P01-CA125066
6 · The paper itself

Abstract

aimBrucea javanica was studied to identify nuclear factor kappaB (NF-κB) inhibitors exhibiting reactive oxygen species (ROS) intracellular amplification. MATERIAL AND

methodsEight compounds were evaluated for selective cytotoxicity using HT-29, HeLa, and HL-60 cells, and in a NF-κB assay. Active compounds were then tested using ROS and mitochondria transmembrane potential (MTP) assays. NF-κB and nuclear factor activated T-cell (NFAT) translocation were also assessed using their respective whole cell assays.

resultsBruceajavanone B, bruceantin, bruceine A, (-)-hydnocarpin, and chrysoeriol exhibited cytotoxic potential and NF-κB p65 inhibition. Chrysoeriol exhibited selective cytotoxicity against leukemia cells with greater potency and also showed an ability to up-regulate NFAT transcriptional pathways through the amplification of intracellular ROS, in the presence of H2O2, to a greater degree than bruceantin and bruceine.

conclusionChrysoeriol selectively kills leukemic cells and potentiates the amplification of ROS levels. Therefore, chrysoeriol could serve as a potential chemotherapeutic modifier for leukemia chemotherapy since leukemia cells have a higher susceptibility to elevated ROS levels.

Indexed as

BruceaCell Line, TumorFlavonesFlavonoidsFlavonolignansHumansMembrane Potential, MitochondrialNFATC Transcription FactorsNF-kappa BPlant ExtractsQuassinsReactive Oxygen SpeciesTriterpenesbruceajavanin Bbruceantinbruceine AchrysoeriolFlavonesFlavonoidsFlavonolignanshydnocarpinNFATC Transcription FactorsNF-kappa BPlant ExtractsQuassinsReactive Oxygen SpeciesTriterpenes

Identifiers

PMID20944100
PMCPMC3013507
OpenAlexW2144578753

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.